Years ago, in the ancient past of HRT when we knew much less bout the hormone components of HRT and BHRT was not yet used by most Gyn and medical practitioners’ progesterone was believed to have one and only one purpose.
It was thought that its only, or at least primary value, was in women who had a uterus and it was considered important for one and only one purpose to prevent Endometrial-Uterine Cancer.
Time has passed and now after some 70 years of using Female Replacement Hormone Therapy, we know differently. We now know that progesterone has multiple values as part of any HRT or BHRT regime.
One of the reasons progesterone was frowned upon is that it seemed that it have no value; if she was not going to become pregnant, it had no value. This came from the fact that progesterone is made by the woman’s body at the time of ovulation. It was released to support her becoming pregnant and maintaining her pregnancy. Obviously, it was reasoned, if pregnancy could no longer occur, the woman’s uterus had been removed and there was no longer any endometrium) then progesterone would no longer be needed. We now know that is a very shortsighted and incorrect observation.
As with everything in life, what has value can also often have risk or problems associated with it. This is as true of progesterone as everything in the medical field.
While progesterone is a critical component of BHRT for its protective effects on the endometrium and its role in alleviating menopausal symptoms, it’s always must be used carefully weighing positive affects against potential negative risks, particularly concerning breast cancer and cardiovascular health. I do not believe that any woman should use any of the many synthetic progestins/progestogens for long-term treatment of menopause. Individualized treatment plans and ongoing monitoring are essential to optimize benefits and minimize adverse effects.
Article by Dr. Allen Lawrence, M.A., M.D., Ph.D.